Today (Monday 27 November) marks the original deadline date for the Drug Supply Chain Security Act (DSCSA). While the US Food and Drug Administration (FDA) has delayed its enforcement of compliance with these serialisation requirements by a year, pharma is still required to legally comply and as such should not sit on its laurels. Here, we feature some comments from industry experts on the DSCSA and the impact a lack of preparedness may have…
Serialisation
Carlos Machado — serialisation director US, SEA Vision